Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules
- 30 September 2006
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 71 (2-3) , 282-292
- https://doi.org/10.1016/j.antiviral.2006.04.011
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Designing a Pronucleotide Stratagem: Lessons from Amino Acid Phosphoramidates of Anticancer and Antiviral PyrimidinesMini-Reviews in Medicinal Chemistry, 2004
- Aryloxy Phosphoramidate Triesters as Pro-TidesMini-Reviews in Medicinal Chemistry, 2004
- Non-inhibition of Acetylcholinesterase bycyclosal NucleotidesNucleosides, Nucleotides and Nucleic Acids, 2003
- Aryl-Substituted and Benzo-Annulated CycloSal-Derivatives of 2′,3′-Dideoxy-2′,3′-Didehydrothymidine Monophosphate — Correlation of Structure, Hydrolysis Properties and Anti-HIV ActivityAntiviral Chemistry and Chemotherapy, 2002
- Strategies in the design of antiviral drugsNature Reviews Drug Discovery, 2002
- Antiviral Activity of Cyclosaligenyl Prodrugs of Acyclovir, Carbovir and AbacavirAntiviral Chemistry and Chemotherapy, 2001
- Cyclosaligenyl-2′,3′-didehydro-2′,3′-dideoxythymidine Monophosphate: Efficient Intracellular Delivery of d4TMPMolecular Pharmacology, 2000
- Intracellular Metabolism ofCycloSaligenyl 3′-Azido-2′,3′-dideoxythymidine Monophosphate, a Prodrug of 3′-Azido-2′,3′-dideoxythymidine (Zidovudine)Molecular Pharmacology, 1999
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- Biochemical aspects of the selective antiherpes activity of nucleoside analoguesBiochemical Pharmacology, 1984